Trial Profile
Effect of Immunomodulatory Agents on Cortical Inflammatory Lesions in Patients with Relapsing-Remitting Multiple Sclerosis: A 2-Year Longitudinal Comparison Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Dec 2012
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary) ; Interferon beta-1a (Primary) ; Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.